Few new insecticides have been produced for control of
disease vectors for public health in developing countries
over the past three decades, owing to market constraints,
and the available insecticides are often poorly
deployed. The Innovative Vector Control Consortium
will address these market failures by developing a
portfolio of chemical and technological tools that will
be directly and immediately accessible to populations in
the developing world. The Bill and Melinda Gates
Foundation has supported this new initiative to enable
industry and academia to change the vector control
paradigm for malaria and dengue and to ensure that
vector control, alongside drugs, case management and
vaccines, can be better used to reduce disease.